Dasatinib (Sprycel) - adult acute lymphocytic leukemia (Ph(+) ALL)
1. Can anyone provide information about the experiences of adult acute lymphocytic leukemia (Ph(+) ALL) patients who stopped taking Dasatinib (Sprycel) after going into remission and completing consolidation therapy? A stem cell transplantation was not and will not be performed.
2. What information and/or research is there on continuing on Dasatinib (Sprycel) after Philadelphia chromosome positive adult acute lymphocytic leukemia (Ph(+) ALL) patients go into remission and complete consolidation therapy to help keep the leukemia from coming back? A stem cell transplantation was not and will not be performed.
Thank you
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.5K Cancer specific
- 2.8K Anal Cancer
- 443 Bladder Cancer
- 308 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 395 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 671 Leukemia
- 791 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 234 Multiple Myeloma
- 7.1K Ovarian Cancer
- 55 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 534 Sarcoma
- 718 Skin Cancer
- 646 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards